Streptococcus pyogenes
, a leading human pathogen, is responsible for a wide range of diseases, including skin and soft tissue infections and severe invasive diseases.
S. pyogenes
produces a large arsenal of virulence factors, including several immune evasion factors. We have identified an open reading frame (
spy0136
) in the
S. pyogenes
SF370 genome encoding a protein of unknown function. Using recombinant Spy0136 in a pull-down assay with human plasma and ELISA, we have identified four complement proteins (C1r, C1s, C3, and C5) as binding partners. Treatment of the complement proteins with PNGase F abrogated binding to C1s, C3, and C5, indicating glycan-dependent interactions. rSpy0136 inhibited complement-mediated hemolysis and interfered with all three complement pathways in a Wieslab complement assay. Furthermore, rSpy0136 inhibited deposition of the C3b opsonin and the membrane attack complex (MAC) on the surface of
S. pyogenes
. We therefore named the previously unknown protein ‘complement evasion factor’ (CEF).
An
S. pyogenes Δspy0136/cef
deletion mutant showed decreased virulence in an
in-vitro
whole blood killing assay and a
Galleria mellonella
(wax moth) infection model. Furthermore, an
L. lactis spy0136/cef
gain-of-function mutant showed increased survival during growth in whole human blood. Analysis of serum samples from patients with invasive
S. pyogenes
revealed Spy0136/CEF sero-conversion indicating expression during disease. In summary, we have identified a novel
S. pyogenes
immune evasion factor that binds to several complement proteins to interfere with complement function. This is the first example of a
S. pyogenes
virulence factor binding to several different target proteins via glycan-dependent interactions.